This site is intended for US Residents only.

Selected Important Safety Information

  • Do not use ELOCTATE if you have had an
    allergic reaction to it in the past.
Please see below for additional Important Safety
Information and full Prescribing Information.
TELL US WHAT MATTERS TO YOU
Select a MyELOCTATE Peer with a story just like yours.
Being a caregiver of someone with Hemophilia can bring challenges, as well as unexpected rewards. But often the hardest part of your journey is seeking answers. That’s why we’re dedicated to helping caregivers like you learn about a treatment to consider discussing with your child’s healthcare provider.
The recommended starting regimen is 50 IU/kg of ELOCTATE administered every 4 days. Adjust the regimen based on patient response, with dosing in the range of 25-65 IU/kg at 3-5 day intervals.

For children under 6 years old, the recommended starting regimen is 50 IU/kg of ELOCTATE administered twice weekly. Adjust the regimen based on patient response with dosing in the range of 25-65 IU/kg at 3-5 day intervals. More frequent or higher doses up to 80 IU/kg may be required.
Could ELOCTATE be right for your child?
Take a moment to learn about the potential
benefits and risks of ELOCTATE.
You want to get out there, explore, and enjoy the adventure of life. We get it. That’s why we’re doing our part to help you learn about a treatment to consider discussing with your healthcare provider so you can focus on making time for what matters to you.
The recommended starting regimen is 50 IU/kg of ELOCTATE administered every 4 days. Adjust the regimen based on patient response, with dosing in the range of 25-65 IU/kg at 3-5 day intervals.

For children under 6 years old, the recommended starting regimen is 50 IU/kg of ELOCTATE administered twice weekly. Adjust the regimen based on patient response with dosing in the range of 25-65 IU/kg at 3-5 day intervals. More frequent or higher doses up to 80 IU/kg may be required.
Could ELOCTATE be right for you?
Take a moment to learn about the potential
benefits and risks of ELOCTATE.
You have a lot on your mind already. And perhaps transitioning your treatment isn’t currently one of them. That’s why we’re doing our part to help you learn about a treatment to consider discussing with your healthcare provider so you can focus on making time for what matters to you.
The recommended starting regimen is 50 IU/kg of ELOCTATE administered every 4 days. Adjust the regimen based on patient response, with dosing in the range of 25-65 IU/kg at 3-5 day intervals.

For children under 6 years old, the recommended starting regimen is 50 IU/kg of ELOCTATE administered twice weekly. Adjust the regimen based on patient response with dosing in the range of 25-65 IU/kg at 3-5 day intervals. More frequent or higher doses up to 80 IU/kg may be required.
Could ELOCTATE be right for you?
Take a moment to learn about the potential
benefits and risks of ELOCTATE.

Indications and Important Safety Information

Indications

ELOCTATE [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for: on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes. ELOCTATE is not indicated for the treatment of von Willebrand disease.

Important Safety Information

Do not use ELOCTATE if you have had an allergic reaction to it in the past.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.

Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.

Your body can also make antibodies called, "inhibitors," against ELOCTATE, which may stop ELOCTATE from working properly.

The most frequently occurring side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort. These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, and if bleeding is not controlled after using ELOCTATE.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see full Prescribing Information.